# MVM Life Science Partners: portfolio, investments and team > MVM Life Science Partners is a vc firm based in United Kingdom. 36 investments on record, 2 in the last 12 months, latest Jun 2026. Source: https://millionrounds.com/fund/mvm-life-science-partners (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Investor](https://millionrounds.com/investors) # MVM Life Science Partners Last cheque observed Jun 2026; 36 cheques on record. Deploying now VC firm Debt Growth Seed Deploying now **50%** of best year **2** **cheques in 12 months**, 36 on record Since the last cheque **139** days **00** hrs **00** min **00** sec Median round **$37M** Cheque size, as they say **$20M – $100M** Rounds led **2 of 36** Sole investor **5 rounds** Exits **4 from the portfolio** Mostly in **United States, 56%** Pitch MVM Life Science Partners ## MVM Life Science Partners highlights - 01 2 cheques in the last 12 months - 02 Mostly Series B and Series C: 59% of its rounds - 03 Sole investor in 5 rounds, median $10M - 04 4 exits from the portfolio ## What they do > We provide equity to companies with high growth potential. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** $20M – $100M as they say - **Stages:** Debt Growth Seed Series A - **Based in:** LONDON, United Kingdom - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **36 appearances** - **2026** 1 round - **Jun** **[GT Medical Technologies](https://millionrounds.com/company/gt-medical-technologies)** Series E · US · MVM Partners **$100M** With 5 others - **2025** 3 rounds - **Nov** **[Avanzanite Bioscience BV](https://millionrounds.com/company/avanzanite-bioscience-bv)** Series A · NL · Silicon Canals **$37M** *Led* - **Aug** **[ProVerum Medical](https://millionrounds.com/company/proverum-medical)** Series B · IE · Crunchbase News **$80M** *Led* - **Jan** **[GT Medical Technologies, Inc.](https://millionrounds.com/company/gt-medical-technologies-inc)** Series D · US · MVM Partners **$37M** With 4 others - **2024** 1 round - **Dec** **[OSSIO, Inc.](https://millionrounds.com/company/ossio-inc)** Growth · US · MVM Partners **$28M** With 5 others - **2023** 1 round - **Mar** **[GT Medical Technologies, Inc.](https://millionrounds.com/company/gt-medical-technologies-inc)** Series C · US · Firms' own news pages **$45M** With 3 others - **2018** 1 round - **Sept** **[Providence Medical](https://millionrounds.com/company/providence-medical)** US · FinSMEs **$25M** With 3 others - **2017** 1 round - **May** **[VitalConnect](https://millionrounds.com/company/vitalconnect)** Series C · US · FinSMEs **$33M** With 1 other - **2016** 1 round - **Dec** **[Providence Medical Technology](https://millionrounds.com/company/providence-medical-technology)** US · FinSMEs **$11M** Sole investor - **2015** 1 round - **Apr** **[Onbone Oy](https://millionrounds.com/company/onbone-oy)** Venture · FI **$11M** With 2 others - **2014** 4 rounds - **Jun** **[Vascular Pathways](https://millionrounds.com/company/vascular-pathways)** Debt · US **$5.0M** With 3 others - **May** **[Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics)** Series B · US **$7.0M** With 3 others - **Apr** **[Wilson Therapeutics](https://millionrounds.com/company/wilson-therapeutics)** Series B · SE **$40M** With 3 others - **Feb** **[Cheetah Medical](https://millionrounds.com/company/cheetah-medical)** Series C · US **$29M** With 4 others - **2013** 2 rounds - **Jun** **[Horizon Discovery](https://millionrounds.com/company/horizon-discovery)** Series C · GB · horizondiscovery.com **$10M** With 11 others - **Jan** **[eZono](https://millionrounds.com/company/ezono)** Venture · DE · finsmes.com **$10M** Sole investor - **2012** 2 rounds - **Mar** **[Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics)** Series B · US · prnewswire.com **$28M** With 4 others - **Jan** **[Horizon Discovery](https://millionrounds.com/company/horizon-discovery)** Series C · GB · onbiovc.com **$19M** With 3 others - **2011** 3 rounds - **Aug** **[Beacon Endoscopic](https://millionrounds.com/company/beacon-endoscopic)** Venture · US · masshightech.com **$8.0M** Sole investor - **Jul** **[AccuVein](https://millionrounds.com/company/accuvein)** Series B · US · finsmes.com **$23M** With 1 other - **Jul** **[Vantia Therapeutics](https://millionrounds.com/company/vantia-therapeutics)** Series B · GB · vantiatherapeutics.com **$6.5M** With 2 others - **2010** 3 rounds - **Nov** **[Vascular Pathways](https://millionrounds.com/company/vascular-pathways)** Series B · US · finsmes.com **$14M** With 3 others - **Jul** **[Cara Therapeutics](https://millionrounds.com/company/cara-therapeutics)** Series D · US · fiercebiotech.com **$15M** With 7 others - **Jan** **[Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics)** Series A · US · onbiovc.com **$24M** With 2 others - **2009** 1 round - **Nov** **[BioVex](https://millionrounds.com/company/biovex)** Series F · GB · xconomy.com **$30M** With 4 others - **2008** 1 round - **Aug** **[Serentis](https://millionrounds.com/company/serentis)** Series A · GB **$10M** With 3 others - **2007** 4 rounds - **Dec** **[PregLem](https://millionrounds.com/company/preglem)** Series B · GB **$32M** With 2 others - **Aug** **[Heptares Therapeutics](https://millionrounds.com/company/heptares-therapeutics)** Seed · GB **Undisclosed** Sole investor - **Jun** **[PregLem](https://millionrounds.com/company/preglem)** Series A · GB **$26M** With 2 others - **Jun** **[Serentis](https://millionrounds.com/company/serentis)** Series A · GB **$20M** With 2 others - **2006** 1 round - **Nov** **[Cara Therapeutics](https://millionrounds.com/company/cara-therapeutics)** Series C · US · thefreelibrary.com **$19M** With 4 others - **2005** 1 round - **May** **[Spherics](https://millionrounds.com/company/spherics)** Series C · US **$26M** With 2 others - **2004** 1 round - **Mar** **[Momenta Pharmaceuticals](https://millionrounds.com/company/momenta-pharmaceuticals)** Series C · US **$21M** With 4 others - **2003** 3 rounds - **Sept** **[Xention](https://millionrounds.com/company/xention)** Venture · GB **$6.4M** With 4 others - **May** **[Momenta Pharmaceuticals](https://millionrounds.com/company/momenta-pharmaceuticals)** Series B · US **$19M** With 3 others - **Apr** **[Oxxon Therapeutics](https://millionrounds.com/company/oxxon-therapeutics)** Venture · GB **$24M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **9 named** AI **Ana Isabella Mihov** Member i Form ADV EB **Eric Bednarski** Member i Form ADV HR **Hugo Roy Francis Harrod** Member i Form ADV JY **Jack Yuuki Tanaka** Member i Form ADV KX **Kevin Xu Cheng** Member i Form ADV KE **Kyle Edward Dempsey** Member i Form ADV NJ **Neil James Akhurst** Member i Form ADV ST **Stephen Thomas Reeders** Member i Form ADV TT **Thomas Theodore Casdagli** Member i Form ADV We also hold **11** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$1.1B** gross assets of its funds, 2 advisers combined Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** MVM Partners LLP - **SEC number:** CRD 159225 ## Exits from the portfolio Companies it backed that were later bought or listed **4 in all** **[Heptares Therapeutics](https://millionrounds.com/company/heptares-therapeutics)** Bought by Sosei **Undisclosed** Feb 2015 **[BioVex](https://millionrounds.com/company/biovex)** Bought by [Amgen](https://millionrounds.com/fund/amgen) **$1.0B** Jan 2011 **[PregLem](https://millionrounds.com/company/preglem)** Bought by [Richter Group](https://millionrounds.com/fund/richter-group) **Undisclosed** Oct 2010 **[Oxxon Therapeutics](https://millionrounds.com/company/oxxon-therapeutics)** Bought by Oxford BioMedica **Undisclosed** Mar 2007 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Debt Growth Seed Median round joined **$37M** the round, not its cheque Alone, median **$10M** Led 2 of 36 rounds **6%** - **Said size:** $20M – $100M - **Sole investor:** 5 rounds - **Last cheque:** Jun 2026 - **Exits:** 4 from the portfolio Rounds by stage said on their site - Series B *9* - Series C *8* - Venture *5* - Series A said *5* - Series D *2* - Debt said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) 5 - [Medtech Venture Partners](https://millionrounds.com/fund/medtech-venture-partners) 3 - [NeoMed](https://millionrounds.com/fund/neomed) 3 - [Quaker Partners](https://millionrounds.com/fund/quaker-partners) 3 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 2 - [Apposite Capital](https://millionrounds.com/fund/apposite-capital) 2 **Pitching MVM Life Science Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as MVM Life Science Partners. A count of rooms they were both in, not a relationship either has claimed. [**Novo Holdings A/S** Growth equity **5** rounds together](https://millionrounds.com/fund/novo-holdings-a-s)[**Medtech Venture Partners** VC firm **3** rounds together](https://millionrounds.com/fund/medtech-venture-partners)[**NeoMed** Growth equity **3** rounds together](https://millionrounds.com/fund/neomed)[**Quaker Partners** VC firm **3** rounds together](https://millionrounds.com/fund/quaker-partners)[**Alta Partners** VC firm **2** rounds together](https://millionrounds.com/fund/alta-partners)[**Apposite Capital** VC firm **2** rounds together](https://millionrounds.com/fund/apposite-capital)[**Ascension Ventures** Corporate VC **2** rounds together](https://millionrounds.com/fund/ascension-ventures)[**Ascent Biomedical Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/ascent-biomedical-ventures)[**Atlas Venture** VC firm **2** rounds together](https://millionrounds.com/fund/atlas-venture)[**CHL Medical Partners** VC firm **2** rounds together](https://millionrounds.com/fund/chl-medical-partners)[**Cardinal Partners** Investment bank **2** rounds together](https://millionrounds.com/fund/cardinal-partners)[**DFJ Esprit** VC firm **2** rounds together](https://millionrounds.com/fund/dfj-esprit) ## Recently backed The latest companies MVM Life Science Partners put money into. [**GT Medical Technologies** $100M · Jun 2026](https://millionrounds.com/company/gt-medical-technologies)[**GT Medical Technologies, Inc.** $37M · Jan 2025](https://millionrounds.com/company/gt-medical-technologies-inc)[**VitalConnect** $33M · May 2017](https://millionrounds.com/company/vitalconnect) ## Quick answers about MVM Life Science Partners ### What does MVM Life Science Partners invest in? MVM Life Science Partners invests most often at Series B and Series C (59% of the rounds on record). ### How active is MVM Life Science Partners? 36 investments on record, 2 of them in the last 12 months, and it led 2. The most recent was in Jun 2026. ### What has MVM Life Science Partners invested in recently? Its most recent investments on record: GT Medical Technologies (Series E, Jun 2026), Avanzanite Bioscience BV (Series A, Nov 2025) and ProVerum Medical (Series B, Aug 2025). ### How big are MVM Life Science Partners's cheques? The median round it joins is $37M. It says it writes cheques of $20M to $100M. ### Does MVM Life Science Partners lead rounds? Sometimes: it led 2 of its 36 investments on record (6%). ### Where does MVM Life Science Partners invest? Most of the companies it backs are in the United States (56%) and the United Kingdom (31%). ### Is MVM Life Science Partners investing now? Yes: it is actively investing, with 2 investments in the last 12 months. ### Who does MVM Life Science Partners invest alongside? Most often Novo Holdings A/S (5 rounds together), Medtech Venture Partners (3 rounds together) and NeoMed (3 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=mvm-life-science-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=mvm-life-science-partners)